Search results
High Deep-Remission Rate With Triple Regimen for Relapsed/Refractory CLL
MedPage Today· 4 days agoTime-limited treatment with a three-drug combination for relapsed/refractory chronic lymphocytic ...
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research note issued to investors on Wednesday morning. The brokerage issued a hold rating ...
Pasco County Commissioner Gary Bradford has died
Tampa Bay Times· 6 days agoFirst-term Pasco County Commissioner Gary Bradford died on Sunday after battling leukemia, a diagnosis that he announced not long after he was elected. Pasco employees received notice on Monday ...
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 4 days agoLilly gained approvals for some other new drugs in 2023, like Omvoh for ulcerative colitis and BTK...
Is Bristol Myers Squibb Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 3 days agoIt's a promising blockbuster drug that could generate $4 billion in sales at its peak. In March, the FDA granted accelerated approval for Breyanzi, a...
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest...
KOLR - KSFX Ozarks· 3 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results ...
Super Senior: Newton Baker
WCAX-TV Vermont· 3 days agoFrom piano to poetry to long-distance running, Newton Baker finds fun with everything he takes on.
Critical Survey: Coeptis Therapeutics (COEP) versus The Competition
ETF DAILY NEWS· 3 days agoCoeptis Therapeutics (NASDAQ:COEP – Get Free Report) is one of 289 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We ...
